Arvee Laboratories (India) Ltd. (ARVEE.NS)

INR 147.12

(-2.97%)

Market Cap (In INR)

1.62 Billion

Revenue (In INR)

303.45 Million

Net Income (In INR)

10.51 Million

Avg. Volume

523.00

Currency
INR
Country
Basic Materials
Open
-
Prev. Close
-
Day Range
-
Year Range
117.05-315.0
PE
73.93
EPS
1.99
Beta Value
0.527
ISIN
INE006Z01016
CUSIP
-
CIK
-
Shares
11020000.0
Earnings Annoncement
-

Company Profile

Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Mr. Shalin Sudhakarbhai Patel
Employee Count
-
Website
https://arveelabs.com
Ipo Date
2018-02-22
Details
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.